These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11294105)

  • 1. [Hormonal therapy associated with radiotherapy of advanced carcinoma of the prostate. Comment on the study and interview with Michel Bolla].
    Valdagni R; Zelefsky MJ
    Recenti Prog Med; 2001 Feb; 92(2):130-2. PubMed ID: 11294105
    [No Abstract]   [Full Text] [Related]  

  • 2. [Update of the study on survival with early hormonal therapy associated with radiotherapy (EORTC 22863 Study) in patients with advanced prostatic cancer. Interview with Michel Bolla].
    Bolla M
    Recenti Prog Med; 2001 Feb; 92(2):128-9. PubMed ID: 11294104
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical strategies for improving the radiotherapeutic management of prostate cancer.
    Chuba PJ; Forman JD; Ben-Josef E; Hart KH; Porter AT
    Anticancer Res; 1997; 17(3A):1449-54. PubMed ID: 9179182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combining external beam radiotherapy with prostate brachytherapy: issues and rationale.
    Febles C; Valicenti RK
    Urology; 2004 Nov; 64(5):855-61. PubMed ID: 15533463
    [No Abstract]   [Full Text] [Related]  

  • 5. [Radiotherapy combined with hormonal therapy as treatment method in patients with prostate cancer: still more questions than answers].
    Milecki P
    Przegl Lek; 2005; 62(12):1455-9. PubMed ID: 16786772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Integrated (surgical and hormonal) treatment of advanced prostatic carcinoma. Comment on the study and the interview with Edward M. Messing].
    Prayer Galetti T
    Recenti Prog Med; 2001 Feb; 92(2):126-7. PubMed ID: 11294103
    [No Abstract]   [Full Text] [Related]  

  • 7. Radiotherapy combined with hormonal therapy (RT-HT) in prostate cancer patients with low, intermediate, and high risk of biochemical recurrence: perspective and therapeutic gain analysis.
    Milecki P; Kwias Z; Martenka DJ
    Neoplasma; 2007; 54(1):7-15. PubMed ID: 17203887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormone therapy adjuvant to external beam radiotherapy for locally advanced prostate carcinoma: a complication-adjusted number-needed-to-treat analysis.
    Jani AB; Kao J; Hellman S
    Cancer; 2003 Dec; 98(11):2351-61. PubMed ID: 14635069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Current hormone therapy of prostate cancer].
    Perevodchikova NI; Bukharkin BV
    Vopr Onkol; 1996; 42(4):7-11. PubMed ID: 8928465
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hormone therapy of locally advanced and metastatic prostate carcinoma].
    Rübben H
    Praxis (Bern 1994); 2001 Sep; 90(38):1641-4. PubMed ID: 11675917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intermediate- to high-risk prostate cancer patient treated with radiation therapy.
    Crawford ED; Barqawi A
    Oncology (Williston Park); 2004 Aug; 18(9):1105-10. PubMed ID: 15471196
    [No Abstract]   [Full Text] [Related]  

  • 12. [What is the best strategy of hormonal therapy in the treatment of locally advanced prostate cancer?].
    Ehara H; Nakano M; Deguchi T
    Hinyokika Kiyo; 2006 Jun; 52(6):473-7. PubMed ID: 16848361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A re-assessment of the role of combined androgen blockade for advanced prostate cancer.
    Klotz L; Schellhammer P; Carroll K
    BJU Int; 2004 Jun; 93(9):1177-82. PubMed ID: 15180600
    [No Abstract]   [Full Text] [Related]  

  • 14. [The role of radiotherapy in the management of prostate cancer].
    Bernier J
    Rev Med Suisse; 2007 Jun; 3(114):1472-4. PubMed ID: 17639669
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluating the use of early hormonal therapy in patients with localised or locally advanced prostate cancer.
    Kaisary AV
    Prostate Cancer Prostatic Dis; 2005; 8(2):140-51. PubMed ID: 15852051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnosis and treatment of prostate cancer].
    Auvert J
    Ann Urol (Paris); 1999; 33(4):259-62. PubMed ID: 10510707
    [No Abstract]   [Full Text] [Related]  

  • 17. Controversies in prostate cancer radiotherapy: consensus development.
    Lukka H; Warde P; Pickles T; Morton G; Brundage M; Souhami L;
    Can J Urol; 2001 Aug; 8(4):1314-22. PubMed ID: 11564274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is 6 months of androgen suppression therapy plus radiotherapy of benefit in patients with localized prostate cancer?
    Pollack A; Horwitz EM
    Nat Clin Pract Oncol; 2005 Jan; 2(1):12-3. PubMed ID: 16264846
    [No Abstract]   [Full Text] [Related]  

  • 19. [Is maximal androgenic blockade necessary in the treatment of prostatic cancer?].
    Matveev BP; Bukharkin BV
    Urologiia; 2003; (6):6-10. PubMed ID: 14708235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of prostate cancer with goserelin and radiotherapy.
    Schoen SS
    N Engl J Med; 1997 Dec; 337(23):1693; author reply 1694. PubMed ID: 9411235
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.